Wearable Patch Market Growth
The global wearable patch market was valued at $12,239.7 million in 2019 and is projected to reach $27,820.5 million by 2027, registering a CAGR of 9.6% from 2020 to 2027.
Wearable patches—also known as smart patches or electronic skin—are used for disease monitoring, drug delivery, and diagnostics. They play a vital role in managing health and wellbeing, particularly among elderly patients with chronic conditions such as diabetes and cardiovascular diseases.
Market Drivers
Technological advancements in wearable patches.
Rising prevalence of chronic diseases worldwide.
Growing consumer awareness regarding remote monitoring and digital health.
Features such as continuous patient monitoring, real-time precise data, minimal interference with body movements, and seamless smartphone connectivity further fuel market adoption.
For example, in May 2020, Koninklijke Philips N.V. received USFDA approval for its Philips Biosensor BX100, a disposable wearable patch designed to monitor heart rate and respiratory rate in patients discharged from intensive care units.
Technology Insights
Connected wearable patches are portable, wireless-enabled devices commonly used to monitor vital signs such as heart rate via Bluetooth. These devices incorporate microprocessor controllers and myoelectric technology, while offering compatibility with most mobile operating systems.
They collect data at regular intervals and transmit it to smartphones or laptops, enabling remote patient monitoring and reducing the need for frequent physical consultations.
Market Challenges
High cost of sensor patches (e.g., electrocardiogram patches cost between $300 and $4,500).
Data privacy and security concerns, which may limit adoption.
Segmentation Analysis
By Product
Temperature patch
Blood glucose patch (largest segment, 2019)
Blood pressure patch
Heart rate & ECG patch
Skin care patch
Others
The blood glucose patch segment leads the market due to the increasing need for regular glucose monitoring among diabetic patients to manage hyperglycemia and hypoglycemia.
By End Use
Healthcare
Fitness & Sports (fastest-growing segment)
The fitness & sports segment is expected to grow significantly, driven by rising adoption among athletes. For instance, Abbott Laboratories’ Libre Sense Glucose Sport Biosensor provides real-time glucose insights to help athletes optimize nutrition and performance during training and competition.
By Region
North America
Europe
Asia-Pacific (fastest CAGR)
LAMEA
Asia-Pacific dominates growth potential due to its large population base, rising health awareness, and growing disposable income. Increasing focus on cost-effective clinical care further boosts adoption in the region.
Competitive Landscape
The market is highly competitive, with leading players focusing on product launches, mergers & acquisitions, and partnerships to strengthen their market presence.
In June 2020, Abbott Laboratories received USFDA approval for its FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) system, expanding its diabetes management portfolio.
Key Players
Abbott Laboratories
iRhythm Technologies, Inc.
Johnson & Johnson Services, Inc.
Koninklijke Philips N.V.
L’Oréal Group
LifeSignals, Inc.
Medtronic Plc (Zephyr Technology Corporation)
Qualcomm Technologies, Inc.
VitalConnect, Inc.
VivaLNK
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the global wearable patch market size along with the current trends and future estimations to elucidate the imminent investment pockets
- It offers wearable patch market analysis from 2020 to 2027, which is expected to enable stakeholders to capitalize on the prevailing opportunities in the market
- A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global wearable patch market growth
Read More:
Operating Room Management Market Worth USD 10.0 billion by 2031 at a CAGR of 13.0%
Chromatography Market is witnessing a CAGR of 5.8% from 2021 to 2030
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
